U.S. v. Ara Aprahamian

Ara Aprahamian was charged with engaging in two conspiracies to suppress and eliminate competition by agreeing to allocate customers and rig bids for, and stabilize, maintain, and fix prices of, generic drugs sold in the United States from at least as early as Spring 2013 and continuing until at least 2015.